Cleared Traditional

Infusion Sets for Single Use (K221075) - FDA 510(k) Clearance

Class II General Hospital device cleared through predicate-based substantial equivalence - typically does not require clinical trials.

K221075 · Sichuan Prius Biotechnology Co., Ltd. · General Hospital
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Nov 2022
Decision
223d
Days
Class 2
Risk

K221075 is an FDA 510(k) clearance for the Infusion Sets for Single Use. Classified as Set, Administration, Intravascular (product code FPA), Class II - Special Controls.

Submitted by Sichuan Prius Biotechnology Co., Ltd. (Yibin, CN). The FDA issued a Cleared decision on November 21, 2022 after a review of 223 days - an extended review cycle.

This device falls under the General Hospital FDA review panel, regulated under 21 CFR 880.5440 - the FDA general hospital device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the General Hospital review framework, consistent with the majority of Class II 510(k) submissions.

View all Sichuan Prius Biotechnology Co., Ltd. devices

Submission Details

510(k) Number K221075 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received April 12, 2022
Decision Date November 21, 2022
Days to Decision 223 days
Submission Type Traditional
Review Panel General Hospital (HO)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
94d slower than avg
Panel avg: 129d · This submission: 223d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code FPA Set, Administration, Intravascular
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 880.5440
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most General Hospital devices follow this clearance model.

Regulatory Consultant

Mid-Link Consulting Co, Ltd.
Diana Hong

The regulatory consultant manages the 510(k) submission process on behalf of the applicant - coordinating technical documentation, predicate strategy and FDA communications. Identifying the consultant behind a submission is a key signal for competitive regulatory intelligence.

Regulatory Peers - FPA Set, Administration, Intravascular

All 237
Devices cleared under the same product code (FPA) and FDA review panel - the closest regulatory comparables to K221075.
BD SmartSite™ Needle-Free Connector
K223088 · Care Fusion · Apr 2023
FlowArt® Needle-Free Split Septum Valve
K222889 · Asset Medikal Tasarim San Tic As. · Jan 2023
Infusion Sets for Single Use with Needles
K221069 · Sichuan Prius Biotechnology Co., Ltd. · Nov 2022
Intravenous Needles for Single Use,Safety Intravenous Needles for Single Use
K221078 · Sichuan Prius Biotechnology Co., Ltd. · Nov 2022
NP Medical nCompass Extension Set with Stabilizing Base
K221518 · Np Medical · Nov 2022
AMSafe NeuFlo Needleless Connector
K220267 · Amsino International, Inc. · Oct 2022